Covid-19
Joint Research Initiative
France
OpenCovid19 Initiative
The OpenCovid19 Initiative, supported by the AXA Research Fund, aims to harness the collective expertise and collaboration of volunteer contributors worldwide to develop open-source solutions to address various aspects of the COVID-19 pandemic. This initiative, led by Just One Giant Lab, has mobilized over 4,000 people from 90 countries, resulting in the launch of more than 120 projects, with 50 still under development. Notable achievements include the development of diagnostic tests, open-source algorithms for medical monitoring, and initiatives to assess the pandemic's impact on human rights and combat the spread of fake news. These efforts contribute to the advancement of understanding, prevention, diagnosis, and treatment of COVID-19, showcasing the power of open and participatory research in addressing global challenges.
The OpenCovid19 Initiative not only fosters rapid and affordable development of solutions but also demonstrates the potential of collaborative, interdisciplinary work in addressing urgent societal needs. The diverse range of projects reflects the initiative's broad impact, from innovative diagnostic tests to tools for monitoring and combating misinformation. By leveraging the collective knowledge and resources of global communities, this initiative contributes to the common good by driving advancements in our understanding and response to the COVID-19 pandemic. As a result, the initiative not only accelerates the creation of solutions but also exemplifies the positive impact of open and participatory research on society at large.
 Thomas
 LANDRAIN 
Institution
Just One Giant Lab SAS
Country
France
Nationality
French
Related articles
Pandemics & Infectious Diseases
Covid-19
Drug Delivery
AI & Big Data in Healthcare
AXA Project
France
Billion Molecules Against COVID19 Challenge
The Covid-19 major health crisis has highlighted the need for strong anticipation, interdisciplinarity and massive agility. The “Billion Molecules against COVID-19”... Read more
 André
 LOESEKRUG-PIETRI 
Joint European Disruptive Initiative
Pandemics & Infectious Diseases
Covid-19
Vaccines
Clinical Data & Trials
Biotech- and Nanotechnology
AXA Project
France
Task Force Covid 19
Since early 2020, the AXA Research Fund has collaborated with the Institut Pasteur, a world-renowned biomedical research center, to advance... Read more
 Institut Pasteur
 (PARIS)